A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Zilebesiran Used as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication
Clinical Trial Grant
Administered By
School of Medicine
Awarded By
Alnylam Pharmaceuticals
Start Date
May 26, 2022
End Date
December 31, 2026
Administered By
School of Medicine
Awarded By
Alnylam Pharmaceuticals
Start Date
May 26, 2022
End Date
December 31, 2026